Anna Asklid
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
Journal: Journal of neuro-oncology
Published: September 29, 2025
Comparative proton and photon treatment plans in children treated for neuroblastoma.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 15, 2025
Why are not all paediatric cancer patients treated with protons? A population-based report from Sweden, 2016-2023.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 28, 2025
Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study.
Journal: Journal of neuro-oncology
Published: February 17, 2025
Response Letter to Ameya et al. Correspondence to the Editor: Reirradiation in Paediatric Tumours of the Central Nervous System: Outcome and Side Effects after Implementing National Guidelines.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 20, 2025
Reirradiation in Paediatric Tumours of the Central Nervous System: Outcome and Side Effects After Implementing National Guidelines.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 31, 2024
Complications after proton radiotherapy in children, focusing on severe late complications. A complete Swedish cohort 2008-2019.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 28, 2023
Re-irradiation in Paediatric Tumours of the Central Nervous System: National Guidelines from the Swedish Workgroup of Paediatric Radiotherapy.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 10, 2023
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Journal: British journal of haematology
Published: July 28, 2020
A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy.
Journal: Leukemia & lymphoma
Published: May 26, 2020
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.
Journal: Haematologica
Published: December 06, 2018
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
Journal: Haematologica
Published: June 21, 2018
Last Updated: 09/26/2026